Patients were honored Friday at a special event hosted by the Georgia Cancer Center at Augusta University and Wellstar MCG Health in recognition of World Lymphedema Day.

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced that portfolio company SteerBio, a biotech ...

A team of researchers led by Rice University bioengineer Omid Veiseh has been awarded $18.2 million in funding from the Advanced Research Projects Agency for Health (ARPA-H) to develop a ...

Dayspring is a wearable non-pneumatic compression system that integrates static compression, sequential gradient compression, and muscle activation to support mobility during treatment. It is ...

The end of cancer treatment can be an exciting milestone in a patient’s recovery process, so any lingering health issues can be frustrating. A Baylor College of Medicine plastic surgeon discusses ...

On the occasion of World Lymphedema Day, celebrated today, March 6th, the Pascale Institute in Naples is drawing attention to a still little-known disease that mainly affects women who ...

Lymphedema is swelling that's caused by a collection of too much lymph fluid. It usually affects your arms and legs, but it can happen in other parts of your body as well. This swelling can cause pain ...

DOYLESTOWN, Pa. (WPVI) -- Lymphedema has been a long-standing worry after cancer surgery or radiation, particularly breast cancer. But it's now possible to reduce, or even prevent these swelling ...

Lymphedema caused by cancer treatment is an often-debilitating condition that can last for years or decades. A dedicated research laboratory at MSK is clarifying how this puzzling disease develops and ...

A compression sleeve for lymphedema is a tube-shaped elasticized garment that a person wears on the arm. By putting pressure on the arm, it keeps lymph flowing through the lymphatic system. Lymph is a ...

Tactile Systems Technology has acquired LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future ...